24×7 Online Assistance Email researchnnnn@gmail.com WhatsApp support Hours 24×7
DM · Super-Speciality (Medical)

Viral Hepatitis Thesis Topics for DM Gastroenterology — 103+ titles

Updated November 2026 · reviewed against the current NMC / NBE curriculum

Hand-curated database of 103+ DM Gastroenterology (Viral Hepatitis) dissertation titles, each ready with objectives, synopsis structure and protocol guidance. Unlock the objectives of any title instantly, or get the complete thesis plan — no signup.

103+DM Gastroenterology (Viral Hepatitis) titles
24×7Instant objectives & thesis plans
100%Plagiarism-free, IEC-ready
Browse all 103 titles See a full thesis plan
Viral Hepatitis thesis topics

103 Viral Hepatitis thesis topics, by speciality

This page gathers the Viral Hepatitis titles in our catalogue, 103 in all, drawn from 14 specialities, so you can pick the angle your department supports. The commonest designs here are prospective observational study, hospital-based cross-sectional study, retrospective record-based study; 34 are marked High priority in our review.

DM Gastroenterology (Viral Hepatitis) — Thesis Title List

103 titles · instant objectives
  1. 001

    Determinants of mortality in patients admitted with viral hepatitis at a tertiary care hospital

    Infectious Diseases Hospital-based cross-sectional study Outcome / Prognostic
    Objective
  2. 002

    Clinical profile and predictors of mortality in patients with viral hepatitis

    Infectious Diseases Prospective observational study Outcome / Prognostic
    Objective
  3. 003

    Clinical profile and outcome of acute-on-chronic liver failure precipitated by acute viral hepatitis

    Infectious Diseases Prospective interventional study Comparative / Interventional
    Objective
  4. 004

    Coinfection with hepatitis A and E in acute viral hepatitis and its impact on clinical outcome

    Infectious Diseases Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  5. 005

    Correlation of INR and serum bilirubin with development of acute liver failure in acute viral hepatitis at a tertiary care hospital

    Infectious Diseases Hospital-based cross-sectional study Association / Correlation
    Objective
  6. 006

    Clinical profile and outcome of acute hepatitis E virus infection in adults at a tertiary care hospital

    Infectious Diseases Retrospective record-based study Association / Correlation
    Objective
  7. 007

    Etiological spectrum of acute viral hepatitis and predictors of acute liver failure at a tertiary care hospital

    Infectious Diseases Prospective analytical study Clinical Spectrum / Profile
    Objective
  8. 008

    Treatment pattern and outcome of acute viral hepatitis in routine clinical practice

    Gastroenterology & Hepatology Prospective observational study Outcome / Prognostic
    Objective
  9. 009

    Tenofovir alafenamide versus tenofovir disoproxil fumarate in chronic hepatitis B: comparison of renal function and bone mineral density changes

    Gastroenterology & Hepatology Prospective comparative study Comparative / Interventional
    Objective
  10. 010

    Sustained virological response with sofosbuvir-velpatasvir in chronic hepatitis C including compensated cirrhosis in routine practice

    Gastroenterology & Hepatology Prospective observational study Outcome / Prognostic
    Objective
  11. 011

    Clinical course and maternal outcome of acute hepatitis E in pregnant women

    Gastroenterology & Hepatology Prospective observational study Outcome / Prognostic
    Objective
  12. 012

    Maddrey discriminant function, MELD and Glasgow alcoholic hepatitis score for predicting 28-day mortality in alcoholic hepatitis

    Gastroenterology & Hepatology Prospective observational study Outcome / Prognostic
    Objective
  13. 013

    Lille model at day 7 for predicting response to prednisolone and 90-day survival in severe alcoholic hepatitis

    Gastroenterology & Hepatology Prospective observational study Outcome / Prognostic
    Objective
  14. 014

    N-acetylcysteine plus prednisolone versus prednisolone alone in severe alcoholic hepatitis

    Gastroenterology & Hepatology Randomized controlled trial Comparative / Interventional
    Objective
  15. 015

    Seroprotection after double-dose hepatitis B vaccination in chronic kidney disease and its predictors

    Nephrology & Electrolytes Prospective observational study Outcome / Prognostic
    Objective
  16. 016

    Awareness and coverage of influenza, pneumococcal and hepatitis B vaccination among adults with type 2 diabetes

    Infectious Diseases Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  17. 017

    Seroprevalence of anti-hepatitis E virus IgG among voluntary blood donors at a tertiary-care blood centre

    Donor Screening & TTI Cross-sectional study Cross-sectional Study
    Objective
  18. 018

    METAVIR grading of fibrosis and necroinflammation on liver biopsy in chronic viral hepatitis and its correlation with APRI and FIB-4 scores

    Surgical Pathology & Histopathology Analytical cross-sectional study Association / Correlation
    Objective
  19. 019

    Occult hepatitis B infection among HBsAg-negative blood donors detected by anti-HBc and nucleic acid testing

    Virology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  20. 020

    Coverage of tetanus-diphtheria and hepatitis B vaccination and its determinants among adults in a rural community

    Communicable Diseases & National Programmes Prospective observational study Clinical Spectrum / Profile
    Objective
  21. 021

    Timeliness of birth-dose vaccines (BCG, OPV-0 and hepatitis B) among institutional deliveries at a tertiary care hospital

    Maternal & Child Health Prospective observational study Association / Correlation
    Objective
  22. 022

    Hepatitis B vaccination status and anti-HBs antibody titres among healthcare workers at a tertiary care hospital

    Communicable Diseases & National Programmes Community-based cross-sectional study Community / KAP
    Objective
  23. 023

    AST to platelet ratio index and FIB-4 score as non-invasive markers of liver fibrosis in chronic hepatitis B

    Liver & Renal Markers Hospital-based diagnostic study Diagnostic Accuracy Study
    Objective
  24. 024

    Prevalence of proximal tubular dysfunction and Fanconi syndrome features in patients on long-term tenofovir disoproxil for HIV or hepatitis B

    Electrolytes & Acid-Base Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  25. 025

    Clinical and virological profile of chronic hepatitis B and response to tenofovir at one year

    Viral Hepatitis Prospective observational study Prospective Study
    Objective
  26. 026

    Sustained virological response with directly acting antivirals in chronic hepatitis C: real-world outcomes

    Viral Hepatitis Prospective observational study Prospective Study
    Objective
  27. 027

    Alcohol-related hepatitis: clinical profile, severity scoring and response to corticosteroids

    Other Liver Disease Prospective observational study Prospective Study
    Objective
  28. 028

    Maternal and fetal outcome of hepatitis E infection in pregnancy

    Viral Hepatitis Prospective observational study Prospective Study
    Objective
  29. 029

    Incidence of hepatitis B reactivation in patients receiving chemotherapy or immunosuppressive therapy

    Viral Hepatitis Prospective observational study Prospective Study
    Objective
  30. 030

    Tenofovir in pregnant women with high hepatitis B viral load and the rate of mother-to-child transmission

    Viral Hepatitis Prospective observational study Prospective Study
    Objective
  31. 031

    Validation of Baveno VII recompensation criteria in decompensated alcohol- or hepatitis B-related cirrhosis after control of the primary aetiology

    Chronic Liver Disease Prospective observational study Validation Study
    Objective
  32. 032

    HBsAg loss and hepatitis flares after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B with low quantitative HBsAg

    Viral Hepatitis Prospective observational study Prospective Study
    Objective
  33. 033

    Peginterferon add-on to nucleos(t)ide analogue therapy in chronic hepatitis B with HBsAg below 1500 IU/mL: HBsAg loss at 48 weeks

    Viral Hepatitis Prospective comparative study Comparative Study
    Objective
  34. 034

    Seroprotection after four-dose double-strength hepatitis B vaccination in non-dialysis chronic kidney disease versus maintenance haemodialysis patients

    Viral Hepatitis Prospective comparative study Comparative Study
    Objective
  35. 035

    Demographic and clinical spectrum of acute viral hepatitis with emphasis on progression to acute liver failure at a tertiary care hospital

    Gastroenterology & Hepatology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  36. 036

    Etiological spectrum of acute viral hepatitis (hepatitis A, B, C and E) in adults at a tertiary care hospital

    Gastroenterology & Hepatology Prospective observational study Clinical Spectrum / Profile
    Objective
  37. 037

    Acute viral hepatitis as a precipitant of acute-on-chronic liver failure in adults with cirrhosis at a tertiary care hospital

    Gastroenterology & Hepatology Prospective analytical study Clinical Spectrum / Profile
    Objective
  38. 038

    Comparison of MELD score and King's College criteria in predicting outcome of acute liver failure due to viral hepatitis

    Gastroenterology & Hepatology Retrospective record-based study Diagnostic / Tool Evaluation
    Objective
  39. 039

    Seroprevalence of hepatitis B and hepatitis C infection among patients on maintenance haemodialysis

    Infectious Diseases Retrospective record-based study Diagnostic / Tool Evaluation
    Objective
  40. 040

    Treatment pattern and outcome of viral hepatitis in routine clinical practice

    Infectious Diseases Prospective analytical study Outcome / Prognostic
    Objective
  41. 041

    Etiological spectrum of acute viral hepatitis in adults with emphasis on hepatitis E

    Gastroenterology & Hepatology Prospective analytical study Outcome / Prognostic
    Objective
  42. 042

    Prevalence of occult hepatitis B infection among HBsAg-negative patients with chronic liver disease

    Infectious Diseases Retrospective record-based study Diagnostic / Tool Evaluation
    Objective
  43. 043

    Etiological spectrum and clinical profile of acute viral hepatitis among adults at a tertiary care hospital

    Gastroenterology & Hepatology Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  44. 044

    Clinical profile and predictors of duration of hospital stay in patients with viral hepatitis

    Infectious Diseases Hospital-based cross-sectional study Outcome / Prognostic
    Objective
  45. 045

    Association of quantitative HBsAg with HBV DNA levels in HBeAg-negative chronic hepatitis B infection

    Gastroenterology & Hepatology Hospital-based cross-sectional study Association / Correlation
    Objective
  46. 046

    Prevalence of occult hepatitis B infection among patients on maintenance haemodialysis

    Gastroenterology & Hepatology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  47. 047

    Change in liver stiffness after sustained virological response with direct-acting antivirals in chronic hepatitis C

    Gastroenterology & Hepatology Prospective observational study Outcome / Prognostic
    Objective
  48. 048

    Hepatitis B reactivation among HBsAg-negative anti-HBc-positive patients receiving rituximab-based chemotherapy

    Gastroenterology & Hepatology Retrospective record-based study Outcome / Prognostic
    Objective
  49. 049

    Clinical profile and response to corticosteroids in autoimmune hepatitis among adults

    Gastroenterology & Hepatology Retrospective record-based study Clinical Spectrum / Profile
    Objective
  50. 050

    Granulocyte colony-stimulating factor in steroid non-responsive severe alcoholic hepatitis: effect on 90-day survival

    Gastroenterology & Hepatology Randomized controlled trial Comparative / Interventional
    Objective
  51. 051

    Incidence, causes and outcome of hypoxic hepatitis in patients admitted to the medical intensive care unit

    Gastroenterology & Hepatology Prospective observational study Outcome / Prognostic
    Objective
  52. 052

    Prevalence of hepatitis B and hepatitis C infection among patients on maintenance haemodialysis

    Nephrology & Electrolytes Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  53. 053

    Influenza, pneumococcal and hepatitis B vaccination coverage among patients with autoimmune rheumatic disease on immunosuppressants

    Rheumatology & Immunology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  54. 054

    Sustained virological response at 12 weeks with sofosbuvir-velpatasvir in chronic hepatitis C infection

    Infectious Diseases Prospective observational study Outcome / Prognostic
    Objective
  55. 055

    Seroprevalence of hepatitis B and hepatitis C co-infection among people living with HIV

    Infectious Diseases Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  56. 056

    Frequency of antecedent infections including dengue, hepatitis E and Campylobacter in Guillain-Barre syndrome

    Neurology · Neuromuscular & Peripheral Nerve Prospective observational study Clinical Spectrum / Profile
    Objective
  57. 057

    Socioeconomic status and its association with Maddrey discriminant function and MELD score at presentation in alcohol-associated hepatitis

    Gastroenterology & Hepatology Hospital-based cross-sectional study Association / Correlation
    Objective
  58. 058

    Prevalence of hepatitis B, hepatitis C and HIV infection among multiply transfused children with thalassemia major

    Paediatric Haematology-Oncology Prospective analytical study Clinical Spectrum / Profile
    Objective
  59. 059

    Clinical profile and complications of hepatitis A in children

    Paediatric Gastroenterology & Hepatology Prospective observational study Clinical Spectrum / Profile
    Objective
  60. 060

    Seroprevalence of HIV and hepatitis C among people who inject drugs attending a de-addiction centre

    Substance Use Disorders Retrospective record-based study Clinical Spectrum / Profile
    Objective
  61. 061

    Seroprevalence of syphilis, HIV and hepatitis B among STI clinic attendees at a tertiary care hospital

    Venereology & STIs Hospital-based cross-sectional study Cross-sectional Study
    Objective
  62. 062

    Prevalence of occult hepatitis B infection among HBsAg-negative, anti-HBc-positive blood donors

    Donor Screening & TTI Prospective observational study Cross-sectional Study
    Objective
  63. 063

    Seroprevalence of hepatitis E virus antibodies among blood donors

    Donor Screening & TTI Prospective laboratory study Cross-sectional Study
    Objective
  64. 064

    Hepatitis B vaccination status and anti-HBs antibody titres among regular voluntary blood donors

    Donor Screening & TTI Hospital-based cross-sectional study Cross-sectional Study
    Objective
  65. 065

    Seroprevalence of hepatitis E virus among pregnant women and its association with adverse outcomes

    Virology Hospital-based cross-sectional study Association / Correlation
    Objective
  66. 066

    Hepatitis B vaccination response by anti-HBs titres among healthcare workers

    Immunology & Serology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  67. 067

    HBV DNA load and HBeAg status in chronic hepatitis B and their association with liver enzymes and fibrosis scores

    Virology Hospital-based cross-sectional study Association / Correlation
    Objective
  68. 068

    Hepatitis C virus genotype distribution and its association with viral load

    Virology Retrospective record-based study Clinical Spectrum / Profile
    Objective
  69. 069

    Hepatitis A virus IgM positivity among children and adolescents with acute viral hepatitis

    Virology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  70. 070

    Seroprevalence of hepatitis B, hepatitis C and HIV infection among patients on maintenance haemodialysis

    Immunology & Serology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  71. 071

    Hepatitis D antibody prevalence among HBsAg-positive patients and its association with liver disease severity

    Virology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  72. 072

    HCV viral load and sustained virological response 12 weeks after direct-acting antiviral therapy in chronic hepatitis C

    Virology Prospective observational study Outcome / Prognostic
    Objective
  73. 073

    Hepatitis E virus IgM and HEV RNA in adults with acute viral hepatitis and acute-on-chronic liver failure

    Virology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  74. 074

    Occult hepatitis B infection detected by nucleic acid testing among HBsAg-negative patients on maintenance haemodialysis

    Virology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  75. 075

    Hepatitis B vaccination status and needle-stick injuries among health care workers of a tertiary care hospital

    Communicable Diseases & National Programmes Hospital-based cross-sectional study Community / KAP
    Objective
  76. 076

    Prevalence of hepatitis B surface antigen and associated risk factors among pregnant women attending the antenatal clinic of a tertiary care hospital

    Communicable Diseases & National Programmes Hospital-based cross-sectional study Association / Correlation
    Objective
  77. 077

    Histopathological spectrum of steatohepatitis and fibrosis on intraoperative liver biopsy in patients with gallstone disease and fatty liver undergoing cholecystectomy

    Hepatobiliary & Pancreatic Surgery Prospective observational study Clinical Spectrum / Profile
    Objective
  78. 078

    Maternal and perinatal outcome in pregnancies complicated by hepatitis B surface antigen positivity

    High-Risk Pregnancy Retrospective record-based study Clinical Spectrum / Profile
    Objective
  79. 079

    Prevalence and risk factors of hepatitis B and hepatitis C infection among patients on maintenance hemodialysis

    Haemodialysis & Vascular Access Hospital-based cross-sectional study Association / Correlation
    Objective
  80. 080

    Seroconversion after hepatitis B vaccination in haemodialysis patients and its determinants

    Haemodialysis & Vascular Access Prospective observational study Outcome / Prognostic
    Objective
  81. 081

    Incidence of hepatitis B and hepatitis C seroconversion in haemodialysis units

    Haemodialysis & Vascular Access Retrospective record-based study Clinical Spectrum / Profile
    Objective
  82. 082

    Change in kidney function and proteinuria after direct-acting antiviral therapy in hepatitis C-related kidney disease

    Special Nephrology Prospective observational study Outcome / Prognostic
    Objective
  83. 083

    Frequency of hepatitis B, hepatitis C and HIV-associated membranous nephropathy and remission after antiviral therapy

    Glomerular Diseases Retrospective record-based study Clinical Spectrum / Profile
    Objective
  84. 084

    Knowledge and practice of infection control among haemodialysis unit staff and their association with hepatitis B and C seroconversion in patients

    Haemodialysis & Vascular Access Hospital-based cross-sectional study Community / KAP
    Objective
  85. 085

    Hepatocellular carcinoma surveillance in patients with chronic hepatitis B and cirrhosis: adherence and yield

    Viral Hepatitis Prospective observational study Prospective Study
    Objective
  86. 086

    Etiological spectrum and outcome of acute viral hepatitis in adults with reference to hepatitis A and E

    Viral Hepatitis Prospective observational study Descriptive Study
    Objective
  87. 087

    Clinical, serological and histological profile of autoimmune hepatitis and response to immunosuppression

    Other Liver Disease Prospective observational study Prospective Study
    Objective
  88. 088

    Phases of chronic hepatitis B infection and eligibility for antiviral therapy under current guidelines

    Viral Hepatitis Hospital-based cross-sectional study Cross-sectional Study
    Objective
  89. 089

    Renal and bone outcomes after switching from tenofovir disoproxil to tenofovir alafenamide in chronic hepatitis B

    Viral Hepatitis Prospective observational study Prospective Study
    Objective
  90. 090

    Prevalence of hepatitis D coinfection in patients with chronic hepatitis B

    Viral Hepatitis Hospital-based cross-sectional study Cross-sectional Study
    Objective
  91. 091

    Regression of liver stiffness after sustained virological response in chronic hepatitis C

    Viral Hepatitis Prospective observational study Prospective Study
    Objective
  92. 092

    Response to direct-acting antivirals in chronic hepatitis C in patients on maintenance haemodialysis

    Viral Hepatitis Prospective observational study Prospective Study
    Objective
  93. 093

    Prevalence of occult hepatitis B infection in patients on maintenance haemodialysis

    Viral Hepatitis Hospital-based cross-sectional study Cross-sectional Study
    Objective
  94. 094

    Clinical profile and outcome of acute hepatitis A in adults

    Viral Hepatitis Prospective observational study Descriptive Study
    Objective
  95. 095

    Clinical profile and outcome of hepatocellular carcinoma in steatotic liver disease versus viral hepatitis

    GI Malignancies Prospective observational study Comparative Study
    Objective
  96. 096

    Low-level viraemia on tenofovir or entecavir therapy in chronic hepatitis B and its association with liver stiffness progression

    Viral Hepatitis Prospective observational study Prospective Study
    Objective
  97. 097

    Granulocyte colony-stimulating factor versus standard medical therapy in steroid-ineligible severe alcohol-associated hepatitis: 90-day survival

    Other Liver Disease Randomised comparative trial Comparative Study
    Objective
  98. 098

    Budesonide versus prednisolone for induction of remission in non-cirrhotic autoimmune hepatitis: biochemical response and steroid adverse effects

    Other Liver Disease Randomised comparative trial Comparative Study
    Objective
  99. 099

    Clinical, serological and histological features and steroid withdrawal outcome of drug-induced autoimmune-like hepatitis compared with idiopathic autoimmune hepatitis

    Other Liver Disease Prospective comparative study Comparative Study
    Objective
  100. 100

    Frequency of parvovirus B19, cytomegalovirus and Epstein-Barr virus infection among adults with non-A to E acute hepatitis

    Viral Hepatitis Hospital-based cross-sectional study Cross-sectional Study
    Objective
  101. 101

    Acute viral hepatitis as the precipitant of acute-on-chronic liver failure: frequency, viral aetiology and 90-day transplant-free survival

    Viral Hepatitis Prospective observational study Prospective Study
    Objective
  102. 102

    Hepatitis B reactivation in patients receiving rituximab-based chemotherapy and role of prophylactic antivirals

    Haematological Malignancies Prospective observational study Prospective Study
    Objective
  103. 103

    Prevalence of hepatitis B and C infection at cancer diagnosis and adherence to screening and antiviral prophylaxis before chemotherapy

    Palliative & Supportive Care Prospective audit Audit
    Objective

DM Gastroenterology (Viral Hepatitis) thesis — frequently asked questions

How many DM Gastroenterology (Viral Hepatitis) thesis topics are listed here?

103+ DM Gastroenterology (Viral Hepatitis) thesis topics are listed on this page, organised by subsection of the Gastroenterology (Viral Hepatitis) curriculum. Click "Get Objectives" on any title to unlock its aim, objectives and hypothesis instantly.

Do these Gastroenterology (Viral Hepatitis) topics include the objective and synopsis?

Yes. "Get Objectives" unlocks the research question, aim, primary and secondary objectives, hypothesis and outcome measures. "Full Plan" unlocks the complete synopsis: introduction, review of literature search terms, methodology, sample-size calculation, statistical plan, ethics and timeline — ready to download as Word or PDF.

Are these topics suitable for DNB, DM and FCPS Gastroenterology (Viral Hepatitis) candidates?

Yes — these Gastroenterology (Viral Hepatitis) dissertation titles are aligned with NMC, NBE and DNB Gastroenterology (Viral Hepatitis) curricula and are suitable for DM Gastroenterology (Viral Hepatitis), DNB Gastroenterology (Viral Hepatitis) and FCPS candidates alike. We can also tailor a title to your institution's preferred study design.

Can you help with synopsis writing, protocol, data analysis and journal publication?

Yes. Beyond topic selection we provide end-to-end support: synopsis writing (NMC / NBE format), IEC / IRB-ready protocol drafting, data collection forms, statistical analysis (SPSS / R / STATA), full thesis writing, plagiarism check (Turnitin), and journal publication assistance (SCOPUS, UGC-CARE, PubMed-indexed).

How fast can I get the objective for a topic?

Instantly. After payment, the objectives open on screen in under a minute and the full plan in 1–3 minutes, 24×7. You can also click "WhatsApp" on any title to talk to our team.

WhatsApp